SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-026228
Filing Date
2016-06-08
Accepted
2016-06-08 18:57:32
Documents
1
Period of Report
2016-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 11114
  Complete submission text file 0001179110-16-026228.txt   12687
Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Issuer) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ACTAVIS PLC MORRIS CORP CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
NAVARRE PAUL (Reporting) CIK: 0001637145 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36867 | Film No.: 161704564